Renalytix Plc (RNLXY)
3.39
-0.11
(-3.14%)
USD |
OTCM |
Oct 15, 16:00
Renalytix Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.001M |
| September 30, 2024 | 0.023M |
| June 30, 2024 | -0.001M |
| March 31, 2024 | -0.003M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.059M |
| Date | Value |
|---|---|
| March 31, 2023 | 0.005M |
| December 31, 2022 | -0.064M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.06M |
| March 31, 2022 | -0.334M |
| December 31, 2021 | -0.131M |
| September 30, 2021 | -0.257M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CompuMed, Inc. | 0.00 |
| Quest Diagnostics, Inc. | -134.00M |
| Labcorp Holdings, Inc. | -366.20M |
| Myriad Genetics, Inc. | -3.20M |
| OPKO Health, Inc. | 15.54M |